Phase 1 single dose studies to optimize the pharmacokinetics of DG17, a novel HIV-protease inhibitor pro-drug, using sodium bicarbonate and ritonavir
- Catherine L. Cherry
- , Jennifer F. Hoy
- , Phillip Altman
- , James S. Rowe
- , Henry Krum
- , John Mills
- , Sharon R. Lewin
Research output: Contribution to journal › Article › peer-review
1
Citation
(Scopus)